Abstract |
Practice Pearl: This study demonstrates the effectiveness of the early addition of rosiglitazone to control hyperglycemia after unsuccessful submaximal sulphonylurea monotherapy. Original Article: Rosenstock J, Goldstein BJ, Vinik AI, et al. RESULT Study Group. Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (> 60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study.
|
Authors | Amit Agrawal |
Journal | The Physician and sportsmedicine
(Phys Sportsmed)
Vol. 37
Issue 1
Pg. 146-8
(Apr 2009)
ISSN: 0091-3847 [Print] England |
PMID | 20048503
(Publication Type: Journal Article)
|
Chemical References |
- Blood Glucose
- Glycated Hemoglobin A
- Hypoglycemic Agents
- Thiazolidinediones
- Triglycerides
- Rosiglitazone
- Cholesterol
- Glipizide
|
Topics |
- Age Factors
- Blood Glucose
(analysis)
- Cholesterol
(blood)
- Diabetes Mellitus, Type 2
(drug therapy, metabolism)
- Disease Progression
- Double-Blind Method
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Glipizide
(administration & dosage, adverse effects)
- Glycated Hemoglobin
- Humans
- Hypoglycemic Agents
(administration & dosage, adverse effects)
- Insulin Resistance
- Liver
(enzymology)
- Male
- Middle Aged
- Randomized Controlled Trials as Topic
- Rosiglitazone
- Thiazolidinediones
(adverse effects, therapeutic use)
- Titrimetry
- Treatment Outcome
- Triglycerides
(blood)
|